Come up with a name for your new list and we'll add to it:
vTv Therapeutics raised a round of funding on February 15, 2005. Investors include
National Institutes of Health.
vTv Therapeutics, formerly TransTech Pharma, is a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered small molecule drug candidates to fill signif…